Early detection of cognitive impairment is essential for improving patient outcomes, but primary care settings face significant challenges in screening. This special report summarizes key…
Imagine gradually losing the ability to express yourself—not because you’ve forgotten the words, but because they simply won’t come out. This is the reality for…
The first drugs against Alzheimer’s disease that are intended to slow down the progression of the condition will soon be authorized in Germany. On November…
As Baby Boomers hit retirement, about 1 in 6 Americans is now over the age of 65. The number of Americans living with dementia is…
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that…
A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss…
A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the…
Researchers have developed a cellular fractionation protocol. This method allows for precise analysis of the proteins located in synaptic membranes and in membranes outside the…
A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons at risk of dementia in…
Centiloid guidelines and recommendations released for clinical context-of-use in Alzheimer’s disease
The members of the Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) have announced the publication of a perspective review on the interpretability and clinical application…